Chiba University Hospital and Shiratori Pharmaceutical Co., Ltd. Start Joint Research to Unravel Drug Supply Instability and Quality Issues from Active Pharmaceutical Ingredients (APIs)
NQ Score
0/100
N1 Content Completeness
0
AI Summary (NQ-processed)
Chiba University Hospital and Shiratori Pharmaceutical have begun joint research aimed at structuring drug supply instability and quality issues originating from active pharmaceutical ingredients (APIs) and proposing a package of countermeasures. The research, spanning from May 1, 2026, to March 31, 2027, seeks to resolve challenges in medical settings and ensure a stable supply of pharmaceuticals.